Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Emberton

Showing results (131-140 of 474) with videos related to

Pageof 48
Sort By:
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|May 27, 2025
Should magnetic resonance imaging be considered in every patient before a bladder outflow obstruction procedure?Ivo Donkov, Nikolaos Chatzikrachtis, Abhisekh Chatterjee, et al.
BJU International|June 14, 2008
Progression of benign prostatic hyperplasia: systematic review of the placebo arms of clinical trialsMark Emberton, John M Fitzpatrick, Manuel Garcia-Losa, et al.
Archives of Internal Medicine|March 30, 2011
Time to rethink PSA screeningParas B Singh, Hashim U Ahmed, Lucy Simmons, et al.
JAMA Network Open|March 11, 2021
Benefit, Harm, and Cost-effectiveness Associated With Magnetic Resonance Imaging Before Biopsy in Age-based and Risk-stratified Screening for Prostate CancerThomas Callender, Mark Emberton, Stephen Morris, et al.
European Urology|September 25, 2025
Re: Karolína Menne Guricová, Cédric Draulans, Floris J. Pos, et al. Focal Boost to the Intraprostatic Tumor in External Beam Radiotherapy for Patients with Localized Prostate Cancer: 10-Year Outcomes of the FLAME Trial. J Clin Oncol. In press. https://doi.org/10.1200/JCO-25-00274Marcin Miszczyk, Rafael Sanchez-Salas, Mark Emberton, et al.
Drug Discovery Today|April 27, 2016
The next level of 3D tumour models: immunocompetenceAgata Nyga, Joana Neves, Katerina Stamati, et al.
BMJ Open|February 26, 2015
Evaluating variation in use of definitive therapy and risk-adjusted prostate cancer mortality in England and the USAAshwin Sachdeva, Jan H van der Meulen, Mark Emberton, et al.
The Journal of Urology|August 8, 2006
Response to daily 10 mg alfuzosin predicts acute urinary retention and benign prostatic hyperplasia related surgery in men with lower urinary tract symptomsMark Emberton, Bertrand Lukacs, Haim Matzkin, et al.
Urologic Oncology|January 10, 2015
A randomized controlled trial to investigate magnetic resonance imaging-targeted biopsy as an alternative diagnostic strategy to transrectal ultrasound-guided prostate biopsy in the diagnosis of prostate cancerVeeru Kasivisvanathan, Manit Arya, Hashim U Ahmed, et al.
Lancet (London, England)|July 27, 2017
Diagnostic accuracy of the PROMIS study - Authors' replyHashim U Ahmed, Louise C Brown, Richard Kaplan, et al.
Pageof 48

Showing results (131-140 of 474) with videos related to

Sort By:
Pageof 48
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|May 27, 2025
Should magnetic resonance imaging be considered in every patient before a bladder outflow obstruction procedure?Ivo Donkov, Nikolaos Chatzikrachtis, Abhisekh Chatterjee, et al.
BJU International|June 14, 2008
Progression of benign prostatic hyperplasia: systematic review of the placebo arms of clinical trialsMark Emberton, John M Fitzpatrick, Manuel Garcia-Losa, et al.
Archives of Internal Medicine|March 30, 2011
Time to rethink PSA screeningParas B Singh, Hashim U Ahmed, Lucy Simmons, et al.
JAMA Network Open|March 11, 2021
Benefit, Harm, and Cost-effectiveness Associated With Magnetic Resonance Imaging Before Biopsy in Age-based and Risk-stratified Screening for Prostate CancerThomas Callender, Mark Emberton, Stephen Morris, et al.
European Urology|September 25, 2025
Re: Karolína Menne Guricová, Cédric Draulans, Floris J. Pos, et al. Focal Boost to the Intraprostatic Tumor in External Beam Radiotherapy for Patients with Localized Prostate Cancer: 10-Year Outcomes of the FLAME Trial. J Clin Oncol. In press. https://doi.org/10.1200/JCO-25-00274Marcin Miszczyk, Rafael Sanchez-Salas, Mark Emberton, et al.
Drug Discovery Today|April 27, 2016
The next level of 3D tumour models: immunocompetenceAgata Nyga, Joana Neves, Katerina Stamati, et al.
BMJ Open|February 26, 2015
Evaluating variation in use of definitive therapy and risk-adjusted prostate cancer mortality in England and the USAAshwin Sachdeva, Jan H van der Meulen, Mark Emberton, et al.
The Journal of Urology|August 8, 2006
Response to daily 10 mg alfuzosin predicts acute urinary retention and benign prostatic hyperplasia related surgery in men with lower urinary tract symptomsMark Emberton, Bertrand Lukacs, Haim Matzkin, et al.
Urologic Oncology|January 10, 2015
A randomized controlled trial to investigate magnetic resonance imaging-targeted biopsy as an alternative diagnostic strategy to transrectal ultrasound-guided prostate biopsy in the diagnosis of prostate cancerVeeru Kasivisvanathan, Manit Arya, Hashim U Ahmed, et al.
Lancet (London, England)|July 27, 2017
Diagnostic accuracy of the PROMIS study - Authors' replyHashim U Ahmed, Louise C Brown, Richard Kaplan, et al.
Pageof 48